Sompraz%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp

# Sompraz HP (Pantoprazole HP) ## Overview Pantoprazole HP is a combination product containing pantoprazole, a potassium-competitive acid blocker (PCAB), and potentially other agents for *Helicobacter pylori* eradication. Pantoprazole selectively inhibits the H+/K+-ATPase enzyme system at the secretory surface of gastric parietal cells, thus inhibiting both basal and stimulated gastric acid secretion. The HP designation suggests it is intended for use in combination therapy for *H. pylori* eradication. ## Primary Indications Eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease. ## Adult Dosing The specific dosing regimen for pantoprazole HP will vary based on the combination product and local eradication protocols. Typically, pantoprazole is administered orally twice daily in combination with antibiotics for *H. pylori* eradication. A common regimen includes pantoprazole 40 mg twice daily, plus two antibiotics (e.g., amoxicillin 1000 mg twice daily and clarithromycin 500 mg twice daily, or metronidazole 500 mg twice daily if penicillin-allergic) for 7-14 days. **Maximum dose:** Not to exceed 40 mg twice daily for pantoprazole component in this indication. ## Pediatric Dosing Specific combination products (HP formulations) for pediatric *H. pylori* eradication may not be readily available or may have varying dosing based on age and weight. Pantoprazole alone is dosed in children as follows, but the HP combination requires specific guidance. * **1 to <5 years:** 10 mg once daily * **5 to <12 years:** 10-20 mg once daily * **≥12 years:** 40 mg once daily Dosing for *H. pylori* eradication in pediatric patients should follow established guidelines and may require specialized formulations or compounding. ## Dose Adjustments * **Hepatic Impairment:** No dose adjustment is generally recommended for pantoprazole in patients with mild to moderate hepatic impairment. However, caution and potentially lower doses may be considered in severe hepatic impairment. * **Renal Impairment:** No dose adjustment is necessary for patients with impaired renal function. ## Contraindications * Known hypersensitivity to pantoprazole, any component of the formulation, or substituted benzimidazoles. * Use in combination with other drugs that may interact significantly and contraindicate co-administration. ## Adverse Effects Common adverse effects associated with pantoprazole include headache, diarrhea, nausea, abdominal pain, vomiting, dizziness, and rash. With combination therapy, antibiotic-associated adverse effects (e.g., C. difficile-associated diarrhea, dysgeusia, rash) are also common. ## Key Drug Interactions Pantoprazole is a substrate of CYP2C19 and CYP3A4. * **Drugs dependent on gastric pH for absorption:** Pantoprazole can decrease gastric acidity, potentially affecting the absorption of drugs like ketoconazole, itraconazole, iron salts, and vitamin B12. * **CYP2C19 Substrates:** Pantoprazole may increase the blood levels of drugs metabolized by CYP2C19, such as clopidogrel, diazepam, and phenytoin. * **Methotrexate:** Concomitant use with proton pump inhibitors (PPIs) may elevate methotrexate levels, potentially leading to toxicity. ## Monitoring * **Efficacy:** Confirmation of *H. pylori* eradication (e.g., via urea breath test, stool antigen test, or biopsy-based testing) approximately 4-6 weeks after completion of therapy. * **Adverse Effects:** Monitor for gastrointestinal disturbances, allergic reactions, and antibiotic-related side effects. * **Long-term PPI use:** If used for prolonged periods, monitor for potential risks such as vitamin B12 deficiency, hypomagnesemia, and bone fracture risk, although these are less relevant for short-term *H. pylori* eradication. ## Clinical Pearls * Pantoprazole HP is designed for convenience in *H. pylori* eradication regimens. * Ensure the patient completes the full course of antibiotics and pantoprazole as prescribed. * Educate patients about potential side effects of both pantoprazole and the accompanying antibiotics. * Advise patients to take pantoprazole at least 1 hour before a meal. * Consider resistance patterns in the local area when selecting antibiotic components of the regimen. *** **Disclaimer:** This information is intended for healthcare professionals. Please consult the most current prescribing information and relevant clinical guidelines for complete details before making any treatment decisions.